Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Completed

Conditions studied: Recurrent Cervical Carcinoma, Recurrent Uterine Corpus Carcinoma, Recurrent Uterine Corpus Sarcoma, Stage I Uterine Corpus Cancer, Stage I Uterine Sarcoma, Stage IA Cervical Cancer, Stage IB Cervical Cancer, Stage II Uterine Corpus Cancer, Stage II Uterine Sarcoma, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage III Uterine Corpus Cancer, Stage III Uterine Sarcoma, Stage IV Uterine Corpus Cancer, Stage IV Uterine Sarcoma, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer

In brief

This clinical trial is studying patient, physician, and nurse factors associated with entry onto clinical trials and finishing treatment in patients with primary or recurrent uterine, endometrial, or cervical cancer. Determining how patients make decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.

Key facts

Study ID

NCT01098630

Run by

Gynecologic Oncology Group

People needed

778

Starts

2010-07-01

Expected to finish

2018-01-27

Last updated by the study team

2018-04-12

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Meets 1 of the following criteria:
• Patients with a pathologically confirmed diagnosis of a primary or recurrent invasive cancer of the uterine cervix or uterine corpus (all stages)
• Further treatment is indicated
• Treatment must take place at the GOG institution in which the patient is enrolled
• A GOG physician, nurse, or study coordinator for one of the patients described above
• Any GOG performance status
• Meets 1 of the following criteria:
• Willing and able to complete or be assisted with completion of 2 questionnaires and have limited medical history, treatment details, and demographic data collected
• Patients do not have to speak and write English (can be assisted by an interpreter)
• Willing to have limited medical history, treatment details, and demographic data collected (Patient)
• No patients who refuse treatment
• No concurrent treatment in a GOG treatment trial
• Prior participation in a GOG treatment trial allowed

Where it is running

• University of Arizona Cancer Center-North Campus — Tucson, Arizona, United States
• Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California, United States
• Roy and Patricia Disney Family Cancer Center — Burbank, California, United States
• John Muir Medical Center-Concord Campus — Concord, California, United States
• University of California San Diego — San Diego, California, United States
• John Muir Medical Center-Walnut Creek — Walnut Creek, California, United States
• Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut, United States
• The Hospital of Central Connecticut — New Britain, Connecticut, United States
• Florida Hospital Orlando — Orlando, Florida, United States
• Queen's Medical Center — Honolulu, Hawaii, United States
• University of Hawaii Cancer Center — Honolulu, Hawaii, United States
• Kapiolani Medical Center for Women and Children — Honolulu, Hawaii, United States
• Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho, United States
• Advocate Christ Medical Center — Oak Lawn, Illinois, United States
• Elkhart Clinic — Elkhart, Indiana, United States
• Michiana Hematology Oncology PC-Elkhart — Elkhart, Indiana, United States
• Elkhart General Hospital — Elkhart, Indiana, United States
• Community Howard Regional Health — Kokomo, Indiana, United States
• IU Health La Porte Hospital — La Porte, Indiana, United States
• Michiana Hematology Oncology PC-Mishawaka — Mishawaka, Indiana, United States
• Saint Joseph Regional Medical Center-Mishawaka — Mishawaka, Indiana, United States
• Michiana Hematology Oncology PC-Plymouth — Plymouth, Indiana, United States
• Memorial Hospital of South Bend — South Bend, Indiana, United States
• Michiana Hematology Oncology PC-South Bend — South Bend, Indiana, United States
• Gynecologic Oncology Group of Arizona — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.